Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33978830)
Watch
English
Paclitaxel and carboplatin in bladder cancer: recent developments
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
10908842
retrieved
30 July 2017
review article
1 reference
stated in
Europe PubMed Central
title
Paclitaxel and carboplatin in bladder cancer: recent developments
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
10908842
retrieved
30 July 2017
main subject
bladder cancer
1 reference
based on heuristic
inferred from title
paclitaxel
1 reference
based on heuristic
inferred from title
carboplatin
1 reference
based on heuristic
inferred from title
author name string
Vaughn DJ
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
10908842
retrieved
30 July 2017
publication date
1 July 2000
1 reference
stated in
Europe PubMed Central
PubMed ID
10908842
retrieved
30 July 2017
published in
European Journal of Cancer
1 reference
stated in
Europe PubMed Central
PubMed ID
10908842
retrieved
30 July 2017
volume
36 Suppl 2
1 reference
stated in
Europe PubMed Central
PubMed ID
10908842
retrieved
30 July 2017
page(s)
7-12
1 reference
stated in
Europe PubMed Central
PubMed ID
10908842
retrieved
30 July 2017
cites work
Cancer statistics, 1999.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus recombinant human granulocyte colony-stimulating factor in advanced urothelial carcinoma: an Eastern Cooperative Oncology Group trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Taxol and taxotere in bladder cancer: in vitro activity and urine stability
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel in advanced urothelial carcinoma: its role in patients with renal insufficiency and as salvage therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: an Eastern Cooperative Oncology Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carboplatin-based chemotherapy for bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carboplatin dosage: prospective evaluation of a simple formula based on renal function
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison between a cisplatin-containing regimen and a carboplatin-containing regimen for recurrent or metastatic bladder cancer patients. A randomized phase II study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of paclitaxel and carboplatin in the treatment of advanced urothelial carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine and other new chemotherapeutic agents for the treatment of metastatic bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900076-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0959-8049(00)00076-9
1 reference
stated in
Europe PubMed Central
PubMed ID
10908842
retrieved
30 July 2017
PubMed ID
10908842
1 reference
stated in
Europe PubMed Central
PubMed ID
10908842
retrieved
30 July 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
